Literature DB >> 12963913

Histologic cure of basal cell carcinoma treated with cryosurgery.

Theodore J Giuffrida1, Gloria Jimenez, Keyvan Nouri.   

Abstract

BACKGROUND: Cryosurgery is a method of treatment for basal cell carcinoma (BCC). Despite numerous studies reporting excellent cure rates with cryosurgery, there are no studies in the literature that have shown a histologic cure of BCC.
OBJECTIVE: We sought to show histologically that cryosurgery is an effective cure for well-defined, noduloulcerative BCC of the trunk and upper extremities.
METHODS: Twelve noduloulcerative BCCs of the trunk and proximal upper extremities less than 1 cm were treated with single freeze-thaw cryosurgery using a cryoprobe apparatus with liquid nitrogen. A thermocouple needle measured temperature, with the goal to reach between -50 degrees C and -60 degrees C. One to 2 months later, the site was excised and examined with horizontal step sections throughout the entire tissue.
RESULTS: No tissue specimens had histologic evidence of tumor.
CONCLUSION: Single freeze-thaw cryosurgery provides a histologic cure of well-defined, noduloulcerative BCCs of the trunk and extremities less than or equal to 1 cm.

Entities:  

Mesh:

Year:  2003        PMID: 12963913     DOI: 10.1067/s0190-9622(03)00903-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  [Cryosurgery in dermatology].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2015-11       Impact factor: 0.751

Review 2.  [Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

Authors:  R-M Szeimies; S Karrer; H Bäcker
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

3.  [Ulcus terebrans. Therapy options and their limits].

Authors:  M Sonntag; J Reifenberger; M Megahed; K W Schulte
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

Review 4.  [Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin].

Authors:  C Kunte; B Konz
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.